glp-1 agonists australia An update on agonists: where do they fit in the type 2 diabetes management algorithm? Australia GLP-1 Receptor Agonist Market
Description
Albiglutide (GlaxoSmithKline) is a fusion of two GLP-1 molecules with human albumin, which increases the proteolytic stability of GLP-1 and slows renal clearance, extending the half-life to 120 h
Clinicians must navigate administrative processes that require detailed documentation, justification, and, in some cases, repeated submissions
N Engl J Med 373(1):1122
Pairing this with ongoing lifestyle changes can help support lasting results
Mol Neurobiol (2018) 55(4):300720
Presented at the Alzheimers Association International Conference (AAIC)
